John Hardaway
Surgical Oncology · Shenandoah, TXNPI 1043585185
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Trisalus Life Sciences, Inc. accounts for 89.9% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2023 at $96,938 and has fallen 89.3% since, to $10,345 in 2025. Among surgical oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $1160.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trisalus Life Sciences, Inc.$147K
- Intuitive Surgical$11K
- Histosonics, Inc.$2K
- Stryker$756
- Myriad Genetic Laboratories, Inc.$443
- Integra Lifesciences Corporation$332
- plus $2K from 31 others
What the payments were for
- Consulting fees$42,44026%
- Speaking & faculty fees$85,05652%
- Travel & lodging$23,50414%
- Food & beverage$4,3383%
- Education$8,0005%
- Other$2910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINAV INFUSION SYSTEM$146,744
- Da Vinci Surgical System$10,483
- 1788$728
- myRisk$346
- CYTAL$291
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$148
- BRAFTOVI$120
- SPYGLASS$116
How this compares
$163,629 in reported general payments places this provider in the 95th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 21 | $275 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $264 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Shenandoah
- Diana HookShenandoah$5K
- Loren RourkeShenandoah$5K
- Allison DipasqualeDallas$272K
- Merrick RossHouston$216K
- Steven CurleyTyler$162K
- Suhail SharifFort Worth$137K
- Alfredo Santillan GomezSan Antonio$125K
- Kelly HuntHouston$104K
- Adam YoppDallas$96K
- Peter BeitschDallas$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.